HUT42102A - Process for preparing peptides with pharmaceutical activity - Google Patents

Process for preparing peptides with pharmaceutical activity

Info

Publication number
HUT42102A
HUT42102A HU861409A HU140986A HUT42102A HU T42102 A HUT42102 A HU T42102A HU 861409 A HU861409 A HU 861409A HU 140986 A HU140986 A HU 140986A HU T42102 A HUT42102 A HU T42102A
Authority
HU
Hungary
Prior art keywords
pharmaceutical activity
preparing peptides
activity
peptides
preparing
Prior art date
Application number
HU861409A
Other languages
English (en)
Other versions
HU201776B (en
Inventor
Peter Raddatz
Guenter Hoelzemann
Hans-Eckart Radunz
Johannes Sombroek
Claus J Schmitges
Klaus-Otto Minck
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of HUT42102A publication Critical patent/HUT42102A/hu
Publication of HU201776B publication Critical patent/HU201776B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0227Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/86Renin inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HU861409A 1985-04-03 1986-04-01 Process for producing novel peptides and pharmaceutical preparations containing same HU201776B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853512128 DE3512128A1 (de) 1985-04-03 1985-04-03 Peptide

Publications (2)

Publication Number Publication Date
HUT42102A true HUT42102A (en) 1987-06-29
HU201776B HU201776B (en) 1990-12-28

Family

ID=6267170

Family Applications (1)

Application Number Title Priority Date Filing Date
HU861409A HU201776B (en) 1985-04-03 1986-04-01 Process for producing novel peptides and pharmaceutical preparations containing same

Country Status (10)

Country Link
US (1) US4755592A (hu)
EP (1) EP0198271B1 (hu)
JP (1) JPS61229851A (hu)
AT (1) ATE90359T1 (hu)
AU (1) AU591892B2 (hu)
CA (1) CA1276390C (hu)
DE (2) DE3512128A1 (hu)
ES (1) ES8707553A1 (hu)
HU (1) HU201776B (hu)
ZA (1) ZA862484B (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4729985A (en) * 1985-08-09 1988-03-08 Pfizer Inc. Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues
DE3619508A1 (de) * 1986-06-10 1987-12-17 Merck Patent Gmbh Aminosaeurederivate
DE3640535A1 (de) * 1986-11-27 1988-06-01 Merck Patent Gmbh Peptide
US5268374A (en) * 1988-10-04 1993-12-07 Abbott Laboratories Non-peptide renin inhibitors
IL92011A0 (en) * 1988-10-19 1990-07-12 Abbott Lab Heterocyclic peptide renin inhibitors
US5164388A (en) * 1988-10-19 1992-11-17 Abbott Laboratories Heterocyclic peptide renin inhibitors
US5972719A (en) * 1996-11-05 1999-10-26 Pharmacopeia, Inc. Combinatorial hydroxy-amino acid amide libraries
EP1242064A4 (en) * 1999-11-03 2005-02-09 Smith Howard J & Ass Pty Ltd LIFE-SPECIFIC THERAPY
PE20140880A1 (es) * 2011-02-08 2014-08-06 Merck Patent Gmbh Derivados de aminostatina para el tratamiento de artrosis
EP2877485B1 (de) 2012-07-24 2018-03-14 Merck Patent GmbH Hydroxystatin-derivate zur behandlung von arthrose

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO812612L (no) 1980-08-06 1982-02-08 Ferring Pharma Ltd Enzym-inhibitorer.
CA1258748A (en) 1981-10-08 1989-08-22 Daniel F. Veber Renin inhibitory peptides
US4384994A (en) 1981-10-08 1983-05-24 Merck & Co., Inc. Renin inhibitory peptides
CA1245217A (en) 1981-12-10 1988-11-22 Joshua S. Boger Renin inhibitory peptides having phe su13 xx deletion
FR2531951A1 (fr) * 1982-08-17 1984-02-24 Sanofi Sa Derives peptidiques inhibiteurs de proteases acides, procede pour leur preparation et medicaments qui en contiennent
US4595677A (en) * 1982-12-03 1986-06-17 Ciba-Geigy Corporation Substituted tetrapeptides
AU573735B2 (en) * 1983-02-07 1988-06-23 Aktiebolaget Hassle Peptide analogue enzyme inhibitors
GB8305985D0 (en) * 1983-03-04 1983-04-07 Szelke M Enzyme inhibition
CA1254699A (en) * 1984-03-12 1989-05-23 Jasjit S. Bindra Renin inhibitors containing statine or derivatives thereof
DE3418491A1 (de) * 1984-05-18 1985-11-21 Merck Patent Gmbh, 6100 Darmstadt Diaminosaeurederivate
FR2564844A1 (fr) * 1984-05-25 1985-11-29 Sanofi Sa Nouveaux peptides derives de la statine, procede d'obtention et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
ATE90359T1 (de) 1993-06-15
HU201776B (en) 1990-12-28
ZA862484B (en) 1986-11-26
EP0198271A3 (en) 1990-02-28
JPS61229851A (ja) 1986-10-14
EP0198271B1 (de) 1993-06-09
CA1276390C (en) 1990-11-13
ES553691A0 (es) 1987-08-01
DE3512128A1 (de) 1986-10-09
AU5530286A (en) 1986-10-09
EP0198271A2 (de) 1986-10-22
AU591892B2 (en) 1989-12-21
US4755592A (en) 1988-07-05
DE3688536D1 (en) 1993-07-15
ES8707553A1 (es) 1987-08-01

Similar Documents

Publication Publication Date Title
HU913776D0 (en) Process for the production of heparosane-n,o-sulphates, and medical preparations containing them as active agents
HU9201937D0 (en) Aryl ethers, process for their production, and for the production of medical preparations containing them as active agents
HU913216D0 (en) Process for the production of saturated hydroxy-alkyl-kinoline acids, and of medical preparations containing them
IE862862L (en) Peptides
NO166080C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,8-trifluorkinoliner.
HU910929D0 (en) Process for the production of 2,8-dioxa-bicyclo/3,2,1/octane derivatives and medical preparations containing them
HUT42102A (en) Process for preparing peptides with pharmaceutical activity
NO164982C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
FI892684A (fi) Menetelmä terapeuttisesti aktiivisten 4-okso-imidatso/1,5-a/kinoksaliinijohdannaisten valmistamiseksi
HUT41784A (en) Process for producing 1,8-naphtiridine derivatives and pharmaceutical compositions containing them as active agents
AU588929B2 (en) Amino acid derivatives
HUT46294A (en) Process for production of derivatives of amino acid and medical compounds containing them as active substance
HU9201358D0 (en) 2-amino-pirimidine-4-carboxamide derivatives, process for their production and for the production of medical preparations containing them as active agents
DE3664631D1 (en) Polyprenyl compounds, processes for preparing them, and pharmaceutical composition containing them
HU908400D0 (en) Process for the production of imidazo(4,5-c)pyridine derivatives and medical preparations containing these compounds as active agents
PT84157A (en) Process for preparing heptanoyl-glu-asp-ala-amino acid immunostimmulants
HU912517D0 (en) New 1-diphenyl-methyl-piperazine derivatives, process for their production, and for the production of medical preparations containing thereof
NO860091L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 12-amino-pyridazino(4[,5[:3,4)pyrrolo(2,1-a)isokinolin-derivater.
HUT44753A (en) Process for producing gem-dihalogen-1,8-diamino-4-azaoctane derivatives and pharmaceutical preparations comprising such compounds
FI894813A (fi) Menetelmä terapeuttisesti aktiivisten 2-metoksikarbonyylisubstituoitujen N,N'-di(trimetoksibentsoyyli)piperatsiinijohdannaisten valmistamiseksi
IE873214L (en) Peptides
ATE10934T1 (de) Peptid, verfahren zu dessen herstellung und dessen verwendung.
GR920100423A (el) Ανταγωνιστές 5-ΗΤ4 κινολιζιδινυλ εστέρος.
EP0202523A3 (en) Process for the preparation of 1,3-di(alkoxycarbonylamino) propane
NO164539C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 5-nafthyl-2,4-dimethyl-3h-1,2,4-triazol-3-thion.

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee